TP53 and cancer: Truncations in TP53 preferentially occurred toward the disordered C-terminal tail involved in protein tetramerization (P = 0.0051, one-sample Wilcoxon rank sum test) in which SGMs have been associated with LOF phenotypes of TP53 (27) and where posttranslational modification sites are often mutated in cancer (28).